FEVER IN INFANTS AND YOUNG CHILDREN
I. General issues:
- Can have sepsis without fever--proceed with w/u if
looks sick, even if afebrile!
- 50% of infants under 18mos have nl. rectal temps of
up to 37.8C
- Bundling (in most cases) and teething do not cause
fever
- Axillary temps tend to be lower than rectal temps; the degree of
variation is itself highly variable (BMJ 320:1174, 2000--AFP)
- Keep in mind Kawasaki's Disease
as a non-infectious causes of fever in infancy
- Consider chest x-ray in any child < 5yo
with T > 39.0 and WBC > 20k
- 146 children < 5yo with T > 39.0 and
WBC > 20k but no clinical signs of
pneumonia or other clinically evident source
of infection were underwent CXR; 26% had
occult pneumonia ("definite"
infiltrates on CXR); 74% of these were
described as "well-appearing" and
all of these had SaO2 > 94% (Ann. Emerg.
Med. 33:166, 1999--JW)
- Predictors of occult bacterial infections:
- Absolute peripheral blood Band counts, % bands, and
Band-to-Neutrophil ratio were not found to be
sig. diff in bacterial vs. viral infection, in a
retrospective study of 100 generally healthy children
< 2yo presenting with T > 39'C (or > 38'C if
< 3mo), no clear source on exam, and eventual dx
based on bacterial cx (of blood or urine or CSF, if
done) or viral cx of nasopharyngeal swabs. However,
temp, total WBC, and absolute neutrophil count were
sig. higher in pts with bacterial than those with
viral infections (Arch. Ped. Adol. Med. 153:261,
1999--AFP)
- In a study looking at WBC, PMN count, and CRP, the best single
predictor of occult bacterial infection was an ANC > 10.6 x
10E9, in a study of 256 children 3-36mo presenting to an ED with
temps 39.0-41.3'C. Combining PMN results w/WBC or CRP did not
improve the detection rate (Arch. Ped. Adol. Med. 156:855,
2002--JW)
II. Newborn (<28d), T > 38.0
- 20% will have life-threatening infections.
- Need CBC w/diff, Cx of blood, urine, and CSF; stool
sx if with diarrhea. Also check CSF gm stain, prot,
glu, cell ct (if RBC?s in CSF, spin it; xanthochromia
suggests hemorrhage). CXR if respiratory compromise.
- Hospitalize & give IV ABX pending Cx
III. 4wks-3mos
- If toxic or not meeting low-risk criteria below,
treat as if newborn (see above)
- MAY (but don't need to) treat as outpt with
daily Ceftriaxone 50mg/kg IM to max of 1g and cx of
blood, urine, & CSF, with re-eval in 24h (or with
ur. cx and obs.) if low-risk:
- Previously healthy
- No focal infection other than OM
- WBC 5-15k with <1.5k bands
- Nl u/a
- If with diarrhea, <5WBC/hpf in stool
- If manage as in B, and blood cx pos, admit for r/o
sepsis and IV abx pending all cx
- If manage as in B, and urine cx pos:
- If afebrile and well, outpt PO abx
- If still febrile, admit for r/o sepsis and IV abx
pending all cx
IV. 3-36mos with T>39.0--guidelines per on Pediatrics
92:1, 1993
- If looks toxic, admit for sepsis w/u and IV abx
- If obvious source, treat that
- If have no obvious source, sig. incidence of
bateremia or UTI
- Do CBC w/diff, u/a, blood and urine Cx
- CXR and LP prn focal signs
- Note that in the "post-HIB" era, fewer pts
in this group may actually have occult bacetermia
- In
one series of 9,500 such kids, blood cx were positive
for pathogenic bacteria in 1.6% (mostly
pneumococcus); risk of bacteremia ass'd with higher
temp, WBC, neutrophil count, and band count (Arch.
Ped. Adol. Med. 152:624, 1998--JW)
- In a retrospective review of 2641 immunocompetent pts 2-36mos
presenting with fever (39.0-40.9'C) without an apparent source,
none of whom received abx, among those who had blood cx done, only
3% were positive; only 2 pts developed serious bacterial
infections, and both recovered completely (Arch. Ped. Adol. Med.
156:512, 2002--JW)
V. Antipyresis
- In a study in 464 children 6-36mos old with temp > 38.3'C randomized to
acetaminophen 12.6mg/kd Q6h, ibuprofen 5mg/kg Q8h, or alternating doses of
the two Q4h (all after an initial loading dose of acetaminophen 25mg/kg or
ibuprofen 10mg/kg), all tx continued x 3d. The alternating-therapy
recipients had sig. lower fever and levels of perceived stress than either
of the monotherapy groups (Arch. Pediat. Adol. Med. 160:197, 2006--JW)